In this article, a series of novel conducting copolymers P(FuPy--EDOT) are prepared via cyclic voltammetry electropolymerization method by using N-furfuryl pyrrole (FuPy) and 3,4-ethylenedioxythiophene (EDOT) as comonomers. The molecular structure, surface morphology, electrochemical, and optical properties of the resulting copolymers are characterized in detail upon varying the feed ratios of FuPy/EDOT in the range of 1/1 to 1/9. The results demonstrate that the prepared P(FuPy--EDOT) copolymers with a higher proportion of EDOT units (FuPy/EDOT: 2/8~1/9) possess good redox activity, tunable optical absorption performances, and low band gaps (1.
View Article and Find Full Text PDFErectile Dysfunction (ED) is the leading cause of sexual dysfunction affecting hundreds of millions of men worldwide, and has been described as an important public health problem. The association of five novel anthropometrics related to obesity, lipids and glucose with ED remains unclear. To investigate the association of lipid accumulation products index (LAP), triglyceride glucose index (TyG), waist triglyceride index (WTI), weight-adjusted-waist index (WWI) and a body shape index (ABSI) with ED.
View Article and Find Full Text PDFIn this work, CaWO (CWO) phosphors were successfully synthesized using a high-temperature solid-state method, exhibiting an anomalous far-red/near-infrared (FR-NIR) emission centered at 685 nm. The origin of this FR-NIR emission is confirmed through Raman spectroscopy, X-ray photoelectron spectroscopy (XPS), density functional theory (DFT) calculations, and heterovalent cationic substitution (Y/Na → Ca). These analyses indicate that interstitial oxygen (O) defects within the lattice are primarily responsible for the FR-NIR emission.
View Article and Find Full Text PDFRationale: Zero-event counts are common in clinical studies, particularly when assessing rare adverse events. These occurrences can result from low event rates, short follow-up periods, and small sample sizes. When both intervention and control groups report zero events in a clinical trial, the study is referred to as a double-zero-event study, which presents methodological challenges for evidence synthesis.
View Article and Find Full Text PDFBackground: The safety data of lecanemab in the post-marketing period has yet to be fully investigated in the current literature. We aimed to identify and characterise the safety profile of lecanemab in the post-marketing period.
Methods: We searched and reviewed the reports submitted to the FDA's Adverse Event Reporting System (FAERS).